Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

Dextrose Injection, USP (5%) is a clear, colorless, sterile solution of dextrose supplied in single-dose flexible plastic ADD-VantageTM diluent containers. This dosage form is intended to be used as a diluent for the contents of an ADD-Vantage vial or a single-dose powdered drug vial with a 20 mm closure using the ADD-Vantage ADDAPTORTM.

Unit of Sale

Strength

Volume

NDC 0409-7100-66
Case of 50 – 50 mL bags

5% (2.5 g/50 mL) (50 mg/mL)

50 mL bags

NDC 0409-7100-67
Case of 50 – 100 mL bags

5% (5 g/100 mL) (50 mg/mL)

100 mL bags

NDC 0409-7100-02
Case of 24 – 250 mL bags

5% (12.5 g/250 mL) (50 mg/mL)

250 mL bags

Do not remove the container from the overwrap until intended for use.

Use the product immediately after the introduction of additives.

Storage and Handling

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].

Do not freeze.

To contact Pfizer’s Medical Information Department, please visit www.pfizermedinfo.com or call 1‑800-438‑1985.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

Hospira logo

LAB-1143-4.0

Medication Guide
Download Consumer Medicine Information

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Additional Resources

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.

Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.

Available 9AM-5PM ET Monday to Friday; excluding holidays.

 

Submit a medical question for a Pfizer medicine or a vaccine. 

The submission will be reviewed during our standard business hours.

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information: 
Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.